Company: LENZ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100630
Chunk: 33

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 33
---
 filed as Exhibit 16.1 to New LENZ’s Form 8-K filed with the SEC on March 22, 2024.

During the fiscal years ending December 31, 2023 and 2022 and the subsequent interim period through March 21, 2024, neither New LENZ, nor any party on behalf of New LENZ, consulted with Ernst & Young LLP with respect to either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of the audit opinion that might be rendered with respect to New LENZ’s consolidated financial statements, and no written report or oral advice was provided to New LENZ by Ernst & Young LLP that was an important factor considered by New LENZ in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was subject to any disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable event (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).

Fees Paid to the Independent Registered Public Accounting Firm

The following table presents fees for professional audit services and other services rendered by Ernst & Young LLP to us for the years ended December 31, 2024 and 2023.**

<div align='center'>-19-</div>

|                       |     |   |      2024 |     |   |      2023 |
|:----------------------|:----|:--|----------:|:----|:--|----------:|
| Audit Fees(1)         |     | $ | 1,127,084 |     | $ | 1,532,008 |
| Audit-Related Fees(2) |     |   |         — |     |   |         — |
| Tax Fees(3)           |     |   |         — |     |   |    76,735 |
| All Other Fees(4)     |     |   |         — |     |   |         — |
| Total Fees            |     | $ | 1,127,084 |     | $ | 1,608,743 |

| (1) | “Audit Fees” consist of fees billed for professional services rendered in connection with the audit of our consolidated financial statements, reviews of our quarterly condensed consolidated financial statements and related accounting consultations and services that are normally provided by the independent registered public account